Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Relay Therapeutics Inc RLAY

Healthcare Biotechnology
Relay Therapeutics Inc. is a clinical-stage precision medicine company. The Company is focused on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The Company’s Dynamo platform integrates an array of computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. The... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:RLAY)

Relay Therapeutics Discloses Three New Programs at New Program & Platform Event

GlobeNewswire June 6, 2024

Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608

GlobeNewswire June 5, 2024

Relay Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire May 21, 2024

Relay Therapeutics to Host New Program and Platform Event on June 6, 2024

GlobeNewswire May 13, 2024

Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights

GlobeNewswire May 2, 2024

Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024

GlobeNewswire April 25, 2024

Relay Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire April 11, 2024

Kuehn Law Encourages Investors of Relay Therapeutics, Inc. to Contact Law Firm

Newsfile March 14, 2024

Relay Therapeutics to Participate in Three Upcoming Investor Conferences

GlobeNewswire February 26, 2024
View More News ››

Opinion & Analysis (NDAQ:RLAY)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:RLAY)

Relay Therapeutics to Present at 42nd Annual J.P. Morgan Hea

Breaking News: $RLAY Relay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare ConferenceCAMBRIDGE, Mass., Jan. 02, 2024...
whytestocks - January 2, 2024

To the Moon!

https://discord.gg/P4fHqHzkcN
Gamaliel - August 9, 2021

To the Moon!!!

https://discord.gg/P4fHqHzkcN
Gamaliel - August 9, 2021
View more Bullboard ››

Mandalay Resources Corp.

Mandalay Resources Corp.

Mandalay Resources Corporation is a Canada-based natural resource company with producing assets in Australia (Costerfield ...
View More »